Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar Ptheforester (49.43) Submitted: 11/8/2011 6:05:52 PM : Outperform Start Price: $30.73 BMY Score: +1.90

a strong pharma company with a good pipeline

Report this Post Reply

Featured Broker Partners


Advertisement